Download PDF
Fortschr Neurol Psychiatr 2018; 86(07): 428-433
DOI: 10.1055/s-0044-100504
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Betrachtungen zu einer möglichen Neuregulierung der Cannabispolitik in Deutschland unter Berücksichtigung der Erfahrungen aus den Niederlanden und Colorado

Discussing possible new regulations in german cannabis policy with special regard to the experiences in the Netherlands and Colorado
Peter Neu
Jüdisches Krankenhaus Berlin Akademisches Lehrkrankenhaus der Charite – Universitätsmedizin Berlin
› Author Affiliations
Further Information

Publication History

eingereicht 06 August 2017

akzeptiert 07 January 2018

Publication Date:
20 July 2018 (online)

    Permissions and Reprints

Zusammenfassung

In Deutschland wird seit einiger Zeit zunehmend über eine neue Cannabispolitik nachgedacht. Von vielen Seiten wird die Forderung nach einer Liberalisierung oder Freigabe des Cannabis laut. Der vorliegende Artikel fasst die wichtigsten Erfahrungen der Cannabis-Politik aus den Niederlanden und dem US-Bundesstaat Colorado zusammen und versucht, daraus Schlussfolgerungen für eine mögliche Neuregulierung der Cannabispolitik in Deutschland abzuleiten.

Abstract

For quite a while a discussion has been taking place in Germany whether or not cannabis should be legalized. This article summarizes the experiences of the Dutch coffee shop system and legalization of cannabis use for recreational purposes in Colorado and attempts to derive recommendations for a cannabis policy in Germany.

Schlüsselwörter

Cannabis - Liberalisierung - Deutschland - Niederlande - Colorado

Key words

liberalization - Germany - Netherlands - Colorado - cannabis
 

  • Literatur

  • 1 McGinty EE, Niederdeppe J, Heley K. et al. Public perceptions of arguments supporting and opposing recreational marijuana legalization. Prev Med 2017; 99: 80-86
    CrossrefPubMedGoogle Scholar
  • 2 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
    CrossrefPubMedGoogle Scholar
  • 3 McCoun R. In what sense (if any) is marijuana a gateway drug? Drug Policy Anal Bull 1998; 4: 5-8
    PubMed
  • 4 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
    CrossrefPubMedGoogle Scholar
  • 5 McCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011 106. 1899-1910
    PubMed
  • 6 Bieleman B, Beelen A, Nijkamp R. et al. Coffee shops in the Netherlands 2007. Number of coffee shops and local policies 1999–2007. Groningen: WODC/St. Intraval; 2008
    Google Scholar
  • 7 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
    CrossrefPubMedGoogle Scholar
  • 8 Bieleman B, Beelen A, Nijkamp R. et al. Coffee shops in the Netherlands 2007. Number of coffee shops and local policies 1999–2007. Groningen: WODC/St. Intraval; 2008
    Google Scholar
  • 9 Reinarman C, Cohen PDA, Kaal HL. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health 2004; 94: 836-42
    CrossrefPubMedGoogle Scholar
  • 10 Simons-Morton B, Pickett W, Boyce W. et al. Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada and the Netherlands. International Journal of Drug Policy 2010; 21: 64-69
    CrossrefPubMedGoogle Scholar
  • 11 MacCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011; 106: 1899-1910
    PubMed
  • 12 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Stat Bull 2009 Available at: http://www.emcdda.europa.eu/stats09 (accessed 1 August 2011; archived by Webcite at. http://www.webcitation.org/60cQYIPPY).
    PubMedGoogle Scholar
  • 13 European School Survey Project on Alcohol and Other Drugs (ESPAD). The 2007 ESPAD Report. Av. at http://www.espad.org/documents/Espad/ESPAD_reports/2007/The_2007_ESPAD_Report-FULL_091006.pdf (accessed 1 August 2011; archived by Webcite at. http://www.webcitation.org/60cQwFaQL).
    PubMedGoogle Scholar
  • 14 Gosh TS, Van Dyke M, Maffey A. et al. Medical Marijuana´s Public Health Lessons – Implication for Retail Marijuana in Colorado. New Engl J Med 2015; 372 (11) 991-993
    CrossrefPubMedGoogle Scholar
  • 15 Colorado Department of Revenue Enforcement Division https://www.colorado.gov/pacific/revenue/colorado-marijuana-tax-data (letzter Zugriff 04.04.2017)
    PubMed
  • 16 Marijuana Enforcement Division. Permanent Rules Related to the Colorado Retail Marijuana Code. East Lansing, MI:Marijuana Enforcement Division 2013
    PubMed
  • 17 Marijuana Enforcement Division. Permanent Rules Related to the Colorado Retail Marijuana Code. East Lansing, MI: Marijuana Enforcement Division 2013
    PubMed
  • 18 Olson B. `Chart of the Week: 60% of Cannabis Companies don´t have Bank accounts.` Marijuana Business Daily ( 2015 , December 14 ) abgerufen im Internet http://mjbizdaily.com/chart-week-60-cannabis-companies-dont-bank-accounts/ (letzter Zugriff 04.04.2017).
    PubMedGoogle Scholar
  • 19 Hughes T. Federal bankers: No account for Colo. cannabis credit union. USA Today ( 2015 July 31 ) abgerufen im Internet: https://www.usatoday.com/story/money/business/2015/07/31/federal-bankers-no-account-colo-cannabis-credit-union/30943749/ (letzter Zugriff 04.04.2017). .
    PubMedGoogle Scholar
  • 20 Gosh TS, Van Dyke M, Maffey A. et al. Medical Marijuana´s Public Health Lessons – Implication for Retail Marijuana in Colorado. New Engl J Med 2015; 372 (11) 991-993
    CrossrefPubMedGoogle Scholar
  • 21 Stone D. Cannabis, pesticides and conflicting laws: The dilemma for legalized states and implications for public health. Regulatory Toxicology and Pharmacology 2014; 69 (03) 284-288
    CrossrefPubMedGoogle Scholar
  • 22 Stone D. Cannabis, pesticides and conflicting laws: The dilemma for legalized states and implications for public health. Regulatory Toxicology and Pharmacology 2014; 69 (03) 284-288
    CrossrefPubMedGoogle Scholar
  • 23 Ghosh TS, Vigil DI, Maffey A. et al. Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Prev Med 2017 http://dx.doi.org/10.1016/j.ypmed.2017.02.021
    PubMedGoogle Scholar
  • 24 Kim HS, Hall KE, Genco EK. et al. Marijuana tourism and emergency department visits in Colorado. N Engl J Med 2016; 374 (08) 797-798
    CrossrefPubMedGoogle Scholar
  • 25 Ghosh T, Van Dyke M, Maffey A. et al. The Public Health Framework of Legalized Marijuana in Colorado. Am J Public Health 2016; 106: 21-27
    CrossrefPubMedGoogle Scholar
  • 26 Moore THM, Zammit S, Lingford-Hughes A. et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007; 370: 319-328
    CrossrefPubMedGoogle Scholar
  • 27 Stefanis NC, Dragovic M, Power BD. et al. Age at initiation of cannabis use predicts age at onset of psychosis: the 7-to-8-year-trend. Schizophr Bull 2013; 39 (02) 251-254
    CrossrefPubMedGoogle Scholar
  • 28 Stepniak B, Papiol S, Hammer C. et al. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry 2014; Nov 1 (06) 444-53
    PubMedGoogle Scholar
  • 29 Rounsaville BJ. DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr Bull 2007; 33 (04) 947-52
    CrossrefPubMedGoogle Scholar
  • 30 Murray RM, Quigley H, Quattrone D. et al. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry Oct 2016; 15 (03) 195-204
    PubMedGoogle Scholar
  • 31 Mortler M. Drogen- und Suchtbericht der Beauftragten der Bundesregierung, Juli 2014
    PubMed
  • 32 Ghosh TS, Vigil DI, Maffey A, Tolliver R, Van Dyke M, Kattari L, Krug H, Reed JK, Wolk L. ( 2017 ) Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Prev Med http://dx.doi.org/10.1016/j.ypmed.2017.02.021
    PubMed
  • 33 McCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011 106. 1899-1910
    PubMed
  • 34 Pacula RL, Kilmer B, Wagenaar AC. et al. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health 2014; 104: 1021-28
    CrossrefPubMedGoogle Scholar
  • 35 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569
    CrossrefPubMedGoogle Scholar
  • 36 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569
    CrossrefPubMedGoogle Scholar
  • 37 Englund A, Freeman TP, Murray RM. et al. Can we make cannabis safer? Lancet Psychiatry 2017 Mar 1. pii: S2215-0366(17)30075-5. doi: 10.1016/S2215-0366(17)30075-5. [Epub ahead of print] Review
    PubMed
  • 38 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569
    CrossrefPubMedGoogle Scholar